Study of tumor samples to guide treatment for childhood cancers
Part of Cancer, Eyes & vision clinical trials.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have (or strongly suspect) neuroblastoma, osteosarcoma, Ewing sarcoma, or a soft-tissue sarcoma
- There is visible (gross) tumor that doctors can potentially remove (or you’re being treated and may have samples taken)
- If you have retinoblastoma and need eye removal surgery (enucleation), you may join only if you’re not already on an active retinoblastoma treatment plan
- You must be seen at St. Jude Children’s Research Hospital or a partner hospital
- You (or your legal guardian) must sign consent within 30 days of the first sample being collected
- You must be age 25 or younger when you enroll
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial analyzes the tumor environment in children with solid tumors to find better ways to use immune cells for treatment. It may help develop new cell-based therapies tailored to each child's tumor.
This study collects children’s normal and tumor tissue (or blood-related normal samples) and reads their DNA/RNA to look at genetic information. It may help researchers understand cancer-related changes and improve future testing, even when the goal isn’t to treat you directly.
This study looks at the genetic (DNA) features of tumors in children, teens, and young adults with osteosarcoma, Ewing sarcoma, or synovial sarcoma. It may help researchers better understand these cancers by analyzing a fresh tumor sample and a blood sample.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
This trial uses special lab models (“immune organoids”) to study certain cancers in children and young people. It may help researchers learn what those cancers do and improve future treatment ideas.
This study is looking at children and teens with very rare tumors to learn more about these conditions and improve future care. It aims to gather information from patients treated at participating centers.
Hear when a new Pediatric Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.